Songmin Lee
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
YIAD-0501 directly dissociates aggregates of full-length and N-terminal pyroglutamate-modified forms of Aβ.
Journal: Alzheimer's research & therapy
Published: December 26, 2025
Clearance of amyloid plaque via focused ultrasonication in a mouse model of Alzheimer's disease.
Journal: Theranostics
Published: July 21, 2025
Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers.
Journal: Angewandte Chemie (International ed. in English)
Published: June 25, 2024
Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3-b:4,5-b']dipyridine-Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model.
Journal: Molecular pharmaceutics
Published: June 14, 2024
Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease.
Journal: ACS pharmacology & translational science
Published: January 08, 2024
4-Acyl-3,4-dihydropyrrolo[1,2-a]pyrazine Derivative Rescued the Hippocampal-Dependent Cognitive Decline of 5XFAD Transgenic Mice by Dissociating Soluble and Insoluble Aβ Aggregates.
Journal: ACS chemical neuroscience
Published: May 12, 2023
A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 23, 2022
Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques.
Journal: Angewandte Chemie (International ed. in English)
Published: July 12, 2022
Anti-amyloidogenic indolizino[3,2-c]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β.
Journal: RSC medicinal chemistry
Published: January 29, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026